Skip to main content
Livermore
Livermore
ZHEN

Bicara Therapeutics Inc.

BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002023658

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Bicara Therapeutics Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of BCAX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Q3 2024Change
Holders069+69
Shares036.4M+36.4M
Value$0$927.6M+$927.6M

New holders (69)

Institutions that held Bicara Therapeutics Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to BCAX in Q3 2024
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.6,955,993$177.2M2.04%
Siren, L.L.C.3,072,827$78.3M3.92%
TPG GP A, LLC3,010,425$76.7M1.31%
FMR LLC2,273,792$57.9M0.00%
Omega Fund Management, LLC2,204,650$56.2M35.09%
Deerfield Management Company, L.P. (Series C)1,795,174$45.7M0.68%
Braidwell LP1,657,600$42.2M1.20%
Price T Rowe Associates Inc1,538,934$39.2M0.00%
Fairmount Funds Management LLC1,284,169$32.7M2.65%
Janus Henderson Group PLC1,188,191$30.3M0.02%
FIL Ltd1,013,853$25.8M0.02%
Baker Bros. Advisors LP833,333$21.2M0.22%
Adage Capital Partners GP, L.L.C.800,000$20.4M0.04%
Logos Global Management LP800,000$20.4M2.28%
Deep Track Capital, LP796,852$20.3M0.65%
Wellington Management Group LLP763,943$19.5M0.00%
Alliancebernstein L.P.708,003$18.0M0.01%
Blackstone Group Inc.650,000$16.6M0.08%
Aisling Capital Management LP568,919$14.5M5.55%
First Turn Management, LLC562,391$14.3M2.27%
Rock Springs Capital Management LP445,975$11.4M0.37%
Vestal Point Capital, LP425,000$10.8M0.85%
Point72 Asset Management, L.P.371,962$9.47M0.03%
Millennium Management LLC299,559$7.63M0.01%
Woodline Partners LP277,969$7.08M0.06%
OrbiMed Advisors LLC271,910$6.93M0.13%
Citadel Advisors LLC234,122$5.96M0.01%
Iron Triangle Partners LP200,000$5.09M0.72%
Ameriprise Financial Inc200,000$5.09M0.00%
Boxer Capital, LLC135,000$3.44M0.17%
Nicholas Investment Partners, LP117,523$2.99M0.27%
TD Asset Management Inc102,420$2.61M0.00%
Goldman Sachs Group Inc101,895$2.60M0.00%
Alyeska Investment Group, L.P.72,807$1.85M0.01%
Vanguard Group Inc70,000$1.78M0.00%
Norges Bank70,000$1.78M0.00%
Point72 (DIFC) Ltd55,757$1.42M0.11%
Maven Securities LTD50,000$1.27M0.14%
Geode Capital Management, LLC48,639$1.24M0.00%
Squarepoint Ops LLC44,774$1.14M0.00%
ADAR1 Capital Management, LLC40,440$1.03M0.17%
Samsara BioCapital, LLC35,000$891.5K0.17%
Walleye Capital LLC31,780$809.4K0.01%
Manufacturers Life Insurance Company, The22,859$582.2K0.00%
Soros Fund Management LLCSuperinvestorSoros Fund Management20,000$509.4K0.01%
Point72 Asia (Singapore) Pte. Ltd.18,125$461.6K0.09%
Scientech Research LLC17,973$457.8K0.09%
New York State Common Retirement Fund17,227$438.8K0.00%
Legato Capital Management LLC14,179$361.1K0.04%
Teachers Retirement System of the State of Kentucky14,039$358.0K0.00%
Bank of America Corp13,341$339.8K0.00%
Greenland Capital Management LP12,296$313.2K0.06%
Jane Street Group, LLC12,151$309.5K0.00%
Caxton Corp10,941$278.7K1.15%
Davidson Kempner Capital Management LP10,000$255.1K0.01%
Barclays PLC10,000$254.7K0.00%
Ghisallo Capital Management LLC10,000$254.7K0.01%
Cinctive Capital Management LP9,001$229.3K0.01%
Two Sigma Investments, LP9,000$229.2K0.00%
Federated Hermes, Inc.8,000$203.8K0.00%
UBS Group AG2,790$71.1K0.00%
Morgan Stanley2,000$50.9K0.00%
JPMorgan Chase & Co730$18.6K0.00%
Aster Capital Management (DIFC) Ltd722$18.4K0.00%
Citigroup Inc252$6.42K0.00%
Kessler Investment Group, LLC200$5.09K0.00%
Royal Bank of Canada100$3.00K0.00%
Advisor Group Holdings, Inc.37$9420.00%
MRP Capital Investments, LLC20$5100.00%

Sold out (0)

Institutions that held Bicara Therapeutics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

None.